Fort Washington Investment Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-26,000
Closed -$3.01M 530
2018
Q3
$3.01M Sell
26,000
-8,000
-24% -$903K 0.03% 259
2018
Q2
$4.29M Sell
34,000
-6,000
-15% -$730K 0.04% 229
2018
Q1
$4.33M Hold
40,000
0.04% 238
2017
Q4
$4.38M Buy
+40,000
New +$3.99M 0.04% 264
2014
Q3
Sell
-2,110
Closed -$352K 433
2014
Q2
$352K Sell
2,110
-1,290
-38% -$229K 0.01% 388
2014
Q1
$675K Hold
3,400
0.01% 296
2013
Q4
$649K Sell
3,400
-300
-8% -$55.8K 0.01% 374
2013
Q3
$626K Sell
3,700
-500
-12% -$77.6K 0.02% 349
2013
Q2
$637K Buy
+4,200
New +$595K 0.01% 329

Other funds holding CLB

Fort Washington Investment Advisors's CLB Position: Q4 2018 in Review

Fort Washington Investment Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 26,000 shares — an estimated $3.01M sold.

Fort Washington Investment Advisors first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $4.38M in Q4 2017. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Fort Washington Investment Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 26,000 Core Laboratories shares in Q4 2018, an estimated $3.01M.
  • Fort Washington Investment Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
  • Fort Washington Investment Advisors's Core Laboratories position peaked at $4.38M in Q4 2017.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.